Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence: a systematic review

被引:29
作者
Ross, S
Soroka, D
Karahalios, A
Glazener, CMA
Hay-Smith, EJC
Drutz, HP
机构
[1] Foothills Med Ctr, Dept Obstet & Gynaecol, Calgary, AB T2N 2T9, Canada
[2] Univ Calgary, Dept Obstet & Gynaecol, Calgary, AB T2N 1N4, Canada
[3] Univ Calgary, Dept Family Med & Community Hlth Sci, Calgary, AB T2N 1N4, Canada
[4] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada
[5] Sunnybrook & Womens Coll Hlth Sci Ctr, Ctr Res Womens Hlth, Maternal Infant & Reprod Hlth Res Unit, Toronto, ON, Canada
[6] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada
[7] St Michaels Hosp, Dept Obstet & Gynaecol, Sect Urogynecol & Reconstruct Pelv Surg, Toronto, ON M5B 1W8, Canada
[8] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB9 1FX, Scotland
[9] Univ Otago, Wellington Sch Med & Hlth Sci, Dept Med, Rehabil Teaching & Res Unit, Wellington, New Zealand
[10] Foothills Med Ctr, Dept Obstet & Gynaecol, Calgary, AB T2N 2T9, Canada
关键词
systematic review; incontinence-specific quality of life measures; outcome measurement; psychometric properties; clinical face validity;
D O I
10.1007/s00192-005-1357-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This systematic review examined the use of incontinence-specific quality of life (QOL) measures in clinical trials of female incontinence treatments, and systematically evaluated their quality using a standard checklist. Of 61 trials included in the review, 58 (95.1%) used an incontinence-specific QOL measure. The most commonly used were IIQ (19 papers), I-QoL (12 papers) and UDI (9 papers). Eleven papers (18.0%) used measures which were not referenced or were developed specifically for the study. The eight QOL measures identified had good clinical face validity and measurement properties. We advise researchers to evaluate carefully the needs of their specific study, and select the QOL measure that is most appropriate in terms of validity, utility and relevance, and discourage the development of new measures. Until better evidence is available on the validity and comparability of measures, we recommend that researchers consider using IIQ or I-QOL with or without UDI in trials of incontinence treatments.
引用
收藏
页码:272 / 285
页数:14
相关论文
共 110 条
[1]  
Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
[2]   Effectiveness of pelvic floor muscle exercise therapy supplemented with a health education program to promote long-term adherence among women with urinary incontinence [J].
Alewijnse, D ;
Metsemakers, JFM ;
Mesters, IEPE ;
van den Borne, B .
NEUROUROLOGY AND URODYNAMICS, 2003, 22 (04) :284-295
[3]   Urodynamic and clinical evaluation of 91 female patients with urinary incontinence treated with perineal magnetic stimulation: 1-year followup [J].
Almeida, FG ;
Bruschini, H ;
Srougi, M .
JOURNAL OF UROLOGY, 2004, 171 (04) :1571-1574
[4]   European psychometric validation of the CONTILIFE®:: A Quality of Life questionnaire for urinary incontinence [J].
Amarenco, G ;
Arnould, B ;
Carita, P ;
Haab, F ;
Labat, JJ ;
Richard, F .
EUROPEAN UROLOGY, 2003, 43 (04) :391-404
[5]  
[Anonymous], UROGYNECOLOGY
[6]   ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence [J].
Avery, K ;
Donovan, J ;
Peters, TJ ;
Shaw, C ;
Gotoh, M ;
Abrams, P .
NEUROUROLOGY AND URODYNAMICS, 2004, 23 (04) :322-330
[7]  
Beaulieu Sylvie, 1999, Can J Urol, V6, P692
[8]   Results of a multicenter trial of the CapSure (Re/Stor) continence shield on women with stress urinary incontinence [J].
Bellin, P ;
Smith, J ;
Poll, W ;
Bogojavlensky, S ;
Knoll, D ;
Childs, S ;
Tuttle, J ;
Barada, J ;
Dann, J .
UROLOGY, 1998, 51 (05) :697-706
[9]  
Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO
[10]  
2-A